HA14-1 analogs (University of Minnesota)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameHA14-1 analogs (University of Minnesota)
Drug Alias NameBcl-xL/Bcl-2 antagonists (University of Minnesota)
ClassificationSmall molecules > Peptidomimetic
Mechanisms of ActionApoptosis regulator Bcl-X inhibitors
TargetsApoptosis regulator Bcl-X
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Minnesota
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Minnesota
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A